Minerva

Minerva

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3683 (Published 13 July 2010) Cite this as: BMJ 2010;341:c3683
  1. Markus Braun-Falco, assistant professor,
  2. Christian Kunte, assistant professor
  1. 1Department of Dermatology and Allergology, Ludwig-Maximilians-Universität, 80337 Munich, Germany.
  1. markus.braun-falco{at}med.uni-muenchen.de

    A 34 year old woman with a history of rheumatoid arthritis was treated with sulfasalazine, chloroquine, prednisolone, methotrexate, and nine cycles of abatacept infusions. Over the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe